Evelina Tacconelli - Infectious Diseases

Author Information

Evelina Tacconelli is an established expert in the field of Infectious Diseases, currently affiliated with the Abteilung Innere Medizin I at Universitätsklinikum Tübingen. Her extensive research focuses on antimicrobial resistance, infectious disease epidemiology, and clinical outcomes in infection management. Her work has significantly contributed to understanding and combating infectious diseases, particularly in hospital settings.

Research Contributions

Evelina Tacconelli has made substantial contributions to infectious disease research with a focus on antimicrobial resistance, particularly in the context of multi-drug resistant organisms. In 2022, she co-authored several important studies, including research on the resistome of E. coli ST131, surveillance of antifungal resistance in Europe, and the development of the BLOOMY prediction scores for mortality in bloodstream infections. She has also been involved in COVID-19 related studies, including seroprevalence among healthcare workers and guidelines for SARS-CoV-2 testing in asymptomatic individuals. Her work is instrumental in informing public health strategies and clinical practices in infectious disease management.

Aliases

Evelina Tacconelli is also known by the aliases E Tacconelli and E. Tacconelli. These variations appear frequently in academic publications and citations.

Publication and Citation Metrics

Total Papers	431
Total Citations	21,469
h-index	62

Publications:

Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region

DOI: 10.3390/diagnostics12010213

Year: 2022

Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries

DOI: 10.3390/jof8030249

Year: 2022

The antimicrobial resistance travel tool, an interactive evidence-based educational tool to limit antimicrobial resistance spread.

DOI: 10.1093/jtm/taac045

Year: 2022

VACCELERATE: Volunteer Registry: A European Study Participant Database to Facilitate Clinical Trial Enrolment

DOI: 10.2139/ssrn.4016606

Year: 2022

Omicron Neutralizing and Anti-SARS-CoV-2 S-RBD Antibodies in Naïve and Convalescent Populations After Homologous and Heterologous Boosting With an mRNA Vaccine

DOI: 10.2139/ssrn.4016530

Year: 2022

Development and validation of BLOOMY prediction scores for 14-day and 6-month mortality in hospitalised adults with bloodstream infections: a multicentre, prospective, cohort study.

DOI: 10.1016/s1473-3099(21)00587-9

Year: 2022

COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence

DOI: 10.1017/S0950268822000280

Year: 2022

ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting

DOI: 10.1016/j.cmi.2022.01.007

Year: 2022

Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study

DOI: 10.1016/j.jinf.2022.02.003

Year: 2022

Evaluating BLOOMY and SOFA scores in hospitalised patients - Authors' reply.

DOI: 10.1016/s1473-3099(22)00229-8

Year: 2022

What is Mycobacterium Tuberculosis?

Can Colonization Provide Benefits?

How Do Hand Sanitizers Work?

What is Zika Virus?

How is Ebola Transmitted?

What are Muscle Aches?

What Causes Respiratory Symptoms in Infectious Diseases?

How is Herpes Transmitted?

How Should One Prepare for a Throat Swab?

What are the benefits of using condoms beyond STI prevention?

Partnered Content Networks

Relevant Topics